ArticleInternational ophthalmology2025
Medial wall orbital decompression surgery for the treatment of Graves' ophthalmopathy: follow-up results in a single medical center.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo examine the success rate of endoscopic decompression surgery in Graves' ophthalmopathy.
methodsThis is a retrospective cohort study of all patients who underwent endoscopic decompression surgery at the Rabin Medical Center, Israel, between 2010 and 2022. The data includes post-surgery follow-up time, visual acuity, proptosis outcomes, and post-surgical complications.
resultsThirty patients underwent unilateral or bilateral decompression surgery at our medical centre during the study period, a total of 42 eyes. The mean age at the time of decompression was 49 ± 15.82 years. The reason for surgery was proptosis in twenty-eight patients (93.3%), while only two patients (6.67%) were referred to surgery due to compressive optic neuropathy. The medial wall was decompressed in all of our patients either as a single procedure or in combination with other procedures. Thirteen patients (43.33%) underwent medial wall-only surgery, thirteen patients (43.33%) had medial and lateral wall surgery, and four patients (13.33%) had medial, lateral, and inferior wall decompression. The mean difference between pre-and post-op of the operated eye, measured by Hertel exophthalmometer, was 3.39 ± 2.45 mm (P < 0.001). The mean difference between the operated eye's visual acuity between pre and post-op was 0.04 ± 0.21LogMAR (P = 0.19). The mean follow-up time for the Hertel measurement was 460.10 days (SD = 585.36). We do not report long-term surgical complications.
conclusionIn the TED (thyroid eye disease) patient, endoscopic medial wall decompression can ensure sufficient orbital decompression while minimising complications. The size of the proptosis should be a factor when planning the surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.